A Q3 2020 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$32B

Q3 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.3B-1.0% YoY

Gross Profit

$669M53.1% margin

Operating Income

$230M18.2% margin

Net Income

$199M15.8% margin

EPS (Diluted)

$0.64

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

$290M

Free Cash Flow

$265M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$9.5B

Total Liabilities

$4.6B

Stockholders' Equity

$5.0B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.3B	-1.0%
Gross Profit	$669M	$692M	-3.3%
Operating Income	$230M	$225M	+2.2%
Net Income	$199M	$191M	+4.2%

Revenue Segments

Life Sciences and Applied Markets

$557M44%

Agilent CrossLab

$463M37%

Diagnostics and Genomics

$241M19%

Geographic Segments

Asia Pacific

$488M39%

Americas

$451M36%

Europe

$322M26%